ロード中...
Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
BACKGROUND: Targeted inhibition of protein kinases is now acknowledged as an effective approach for cancer therapy. However, targeted therapies probably have limited success because cancer cells have alternate pathways for survival and proliferation thereby avoiding inhibition. We tested the hypothe...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2005
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1289294/ https://ncbi.nlm.nih.gov/pubmed/16255777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-3-39 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|